451 related articles for article (PubMed ID: 23845884)
61. Development and validation of a systematic UPLC-MS/MS method for simultaneous determination of three phenol impurities in ritonavir.
Venugopal N; Vijaya Bhaskar Reddy A; Madhavi G
J Pharm Biomed Anal; 2014 Mar; 90():127-33. PubMed ID: 24366213
[TBL] [Abstract][Full Text] [Related]
62. Stability-Indicating Reversed-Phase UHPLC Method Development and Characterization of Degradation Products of Almotriptan Maleate by LC-QTOF-MS/MS.
Saibaba B; Vishnuvardhan C; Johnsi Rani P; Satheesh Kumar N
J Chromatogr Sci; 2018 Jan; 56(1):6-17. PubMed ID: 28977362
[TBL] [Abstract][Full Text] [Related]
63. Rapid quantitative determination of related substances and degradants in milnacipran.
Pydimarry SP; Cholleti VK; Venagala RR
J Chromatogr Sci; 2014 Jan; 52(1):42-51. PubMed ID: 23258392
[TBL] [Abstract][Full Text] [Related]
64. A Validated RP-HPLC Method for the Analysis of 1-Fluoronaphthalene and Its Process-Related Impurities.
Karagiannidou EG; Bekiari ET; Vastardi EI
J Chromatogr Sci; 2015 Sep; 53(8):1296-302. PubMed ID: 25713107
[TBL] [Abstract][Full Text] [Related]
65. Validated stability-indicating assay method for simultaneous determination of aceclofenac and thiocolchicoside using RP-HPLC.
Samanthula G; Shrigod VV; Patel PN
Drug Res (Stuttg); 2014 Aug; 64(8):429-35. PubMed ID: 24310363
[TBL] [Abstract][Full Text] [Related]
66. RP-HPLC method for simultaneous estimation of bisoprolol fumarate and hydrochlorothiazide in tablet formulation.
Joshi SJ; Karbhari PA; Bhoir SI; Bindu KS; Das C
J Pharm Biomed Anal; 2010 Jul; 52(3):362-71. PubMed ID: 19926421
[TBL] [Abstract][Full Text] [Related]
67. RP-HPLC separation and characterization of unknown impurities of a novel HIV-protease inhibitor Darunavir by ESI-MS and 2D NMR spectroscopy.
Nageswara Rao R; Ramachandra B; Santhakumar K
J Pharm Biomed Anal; 2013 Mar; 75():186-91. PubMed ID: 23266664
[TBL] [Abstract][Full Text] [Related]
68. Automated statistical experimental design approach for rapid separation of coenzyme Q10 and identification of its biotechnological process related impurities using UHPLC and UHPLC-APCI-MS.
Talluri MV; Kalariya PD; Dharavath S; Shaikh N; Garg P; Ramisetti NR; Ragampeta S
J Sep Sci; 2016 Sep; 39(18):3528-35. PubMed ID: 27488256
[TBL] [Abstract][Full Text] [Related]
69. A validated reversed phase HPLC method for the determination of process-related impurities in almotriptan malate API.
Kumar AP; Ganesh VR; Rao DV; Anil C; Rao BV; Hariharakrishnan VS; Suneetha A; Sundar BS
J Pharm Biomed Anal; 2008 Mar; 46(4):792-8. PubMed ID: 18191357
[TBL] [Abstract][Full Text] [Related]
70. A validated specific stability-indicating RP-HPLC assay method for Ambrisentan and its related substances.
Narayana MB; Chandrasekhar KB; Rao BM
J Chromatogr Sci; 2014 Sep; 52(8):818-25. PubMed ID: 23926121
[TBL] [Abstract][Full Text] [Related]
71. Fesoterodine stress degradation behavior by liquid chromatography coupled to ultraviolet detection and electrospray ionization mass spectrometry.
Sangoi MS; Todeschini V; Steppe M
Talanta; 2011 May; 84(4):1068-79. PubMed ID: 21530781
[TBL] [Abstract][Full Text] [Related]
72. Stability-indicating HPLC-DAD determination of ribavirin in capsules and plasma.
Haggag RS; Belal SF; Hewala II; El Rouby OA
J Chromatogr Sci; 2014 Jul; 52(6):493-500. PubMed ID: 23749878
[TBL] [Abstract][Full Text] [Related]
73. Stability-indicating RP-HPLC method for the quantitative analysis of perindopril erbumine in tablet dosage form.
Dugga HH; Peraman R; Nayakanti D
J Chromatogr Sci; 2014 Apr; 52(4):315-20. PubMed ID: 23690066
[TBL] [Abstract][Full Text] [Related]
74. Quantification of potential impurities by a stability indicating UV-HPLC method in niacinamide active pharmaceutical ingredient.
Thomas S; Bharti A; Tharpa K; Agarwal A
J Pharm Biomed Anal; 2012 Feb; 60():86-90. PubMed ID: 22115882
[TBL] [Abstract][Full Text] [Related]
75. A validated stability-indicating UPLC method for desloratadine and its impurities in pharmaceutical dosage forms.
Rao DD; Satyanarayana NV; Malleswara Reddy A; Sait SS; Chakole D; Mukkanti K
J Pharm Biomed Anal; 2010 Feb; 51(3):736-42. PubMed ID: 19815361
[TBL] [Abstract][Full Text] [Related]
76. Development and Validation of a Stability-Indicating RP-UPLC Method for Determination of Cloxacillin Sodium in Its Bulk Form and Formulation.
Patel N; Contractor P; Keshrala R; Patel PR; Shridhar B
J Chromatogr Sci; 2015 Jul; 53(6):903-8. PubMed ID: 25368408
[TBL] [Abstract][Full Text] [Related]
77. A high pH based reversed-phase high performance liquid chromatographic method for the analysis of aminoglycoside plazomicin and its impurities.
Tan L; Wlasichuk KB; Schmidt DE; Campbell RL; Hirtzer P; Cheng L; Karr DE
J Pharm Biomed Anal; 2012 Jul; 66():75-84. PubMed ID: 22459505
[TBL] [Abstract][Full Text] [Related]
78. Stability-indicating HPLC method for determination of fosamprenavir calcium.
Chilukuri M; Narayanareddy P; Hussianreddy K
J Chromatogr Sci; 2014 Sep; 52(8):781-7. PubMed ID: 23893948
[TBL] [Abstract][Full Text] [Related]
79. A validated stability indicating high performance reverse phase liquid chromatographic method for the determination of cilostazol in bulk drug substance.
Jadhav AS; Pathare DB; Shingare MS
Drug Dev Ind Pharm; 2007 Feb; 33(2):173-9. PubMed ID: 17454049
[TBL] [Abstract][Full Text] [Related]
80. Development and validation of the stability indicating RP-UHPLC method for the determination of the chemical purity and assay of bimatoprost.
Zezula M; Ruszczak M; Maruszak W; Zagrodzka J; Chodynski M; Dams I
J Pharm Biomed Anal; 2019 Sep; 174():348-359. PubMed ID: 31202877
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
